SCINAI IMMUNOTHERAPEUTICS LTD. Increase Decrease In Cash And Cash Equivalents
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Increase Decrease In Cash And Cash Equivalents of -ILS 9.35 million for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-29.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2022-08-29
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease in cash and cash equivalents for the quarter ending 2022-06-30 was -9.35M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease in cash and cash equivalents for the quarter ending 2021-12-31 was 19.36M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease in cash and cash equivalents for the quarter ending 2021-09-30 was -5.21M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease in cash and cash equivalents for the quarter ending 2021-06-30 was -8.69M ILS.
ILS
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 9 month as first filed | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | -9.35M ILS 6-K/A · filed 2022-08-29 | -14.54M ILS 6-K/A · filed 2022-08-29 | |||
| 2021-12-31 | 19.36M ILS derived: 6-K/A 12 month − 6-K/A 9 month · filed 2022-08-29 | 14.15M ILS derived: sum of 2 quarters · filed 2022-08-29 | 5.46M ILS derived: sum of 3 quarters · filed 2022-08-29 | 44.62M ILS 6-K/A · filed 2022-08-29 | |
| 2021-09-30 | -5.21M ILS 6-K/A · filed 2021-12-27 | -13.90M ILS derived: sum of 2 quarters · filed 2022-08-29 | 25.25M ILS 6-K/A · filed 2021-12-27 | ||
| 2021-06-30 | -8.69M ILS 6-K/A · filed 2022-08-29 | 30.46M ILS 6-K/A · filed 2022-08-29 | |||
| 2020-12-31 | -15.35M ILS derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | -29.33M ILS derived: sum of 2 quarters · filed 2022-03-28 | -33.09M ILS derived: sum of 3 quarters · filed 2022-03-28 | -63.05M ILS 20-F · filed 2022-03-28 | |
| 2020-09-30 | -13.98M ILS 6-K/A · filed 2021-12-27 | -17.73M ILS derived: sum of 2 quarters · filed 2021-12-27 | -47.69M ILS 6-K/A · filed 2021-12-27 | -47.69M ILS 6-K · filed 2021-01-28 | |
| 2020-06-30 | -3.75M ILS 6-K · filed 2020-10-02 | -33.72M ILS 6-K · filed 2020-10-02 | |||
| 2019-12-31 | -2.78M ILS derived: 20-F 12 month − 6-K 9 month · filed 2022-03-28 | 38.55M ILS derived: sum of 2 quarters · filed 2022-03-28 | 15.09M ILS derived: sum of 3 quarters · filed 2022-03-28 | -3.42M ILS 20-F · filed 2022-03-28 | |
| 2019-09-30 | 41.33M ILS 6-K · filed 2021-01-28 | 17.87M ILS derived: sum of 2 quarters · filed 2021-01-28 | -636.00K ILS 6-K · filed 2021-01-28 | ||
| 2019-06-30 | -23.46M ILS 6-K · filed 2020-10-02 | -41.97M ILS 6-K · filed 2020-10-02 | |||
| 2018-12-31 | 4.50M ILS 20-F · filed 2021-05-13 | ||||
| 2017-12-31 | 55.68M ILS 20-F · filed 2020-06-12 | ||||
| 2016-12-31 | -17.77M ILS 20-F · filed 2019-04-30 | ||||
| 2015-12-31 | 23.86M ILS 20-F · filed 2018-04-30 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$4.14M 6-K/A · filed 2022-08-29 | |||
| 2021-12-31 | $6.53M derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | $14.35M 20-F · filed 2022-03-28 | ||
| 2021-09-30 | $7.82M 6-K/A · filed 2021-12-27 | |||
| 2020-12-31 | -$19.61M 20-F · filed 2021-05-13 | |||
| 2017-12-31 | $16.06M 20-F · filed 2018-04-30 |